Professor University of Texas at Austin austin, Texas
This will be a case study of how principles of immunology and formulation development enhanced the potency and physical stability of an Ebola Vaccine. Using this example, I will then provide insight through "Lessons Learned" to demonstrate how pharmaceutical scientists can rapidly adapt drug delivery platforms during pandemic situations to effectively formulate newly discovered vaccines for rapid disbursement to hot spots of infection.
Upon completion, participant will be able to identify current barriers to global access to vaccines and biological drugs.
Upon completion, participant will be able to understand the dual roles excipients in vaccines hold - that of stabilization and enhancing potency.
Upon completion, participant will be able to evaluate physical characteristics and biology of an emerging pathogen and to rapidly develop a product which is readily deployable during pandemic situations.